Shareholders Equity: The sum of preferred and common equity items.
FibroGen, Inc (FGEN) had Shareholders Equity of $-196.41M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.74M |
|
$4.64M |
|
$0.25M |
|
$2.49M |
|
$17.66M |
|
$-14.92M |
|
$-1.84M |
|
$-16.76M |
|
$-16.76M |
|
$-16.77M |
|
$-16.77M |
|
$4.64M |
|
$-16.77M |
|
$-14.92M |
|
$-14.59M |
|
100.95M |
|
100.95M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$148.53M |
|
-- |
|
$16.68M |
|
$165.21M |
|
$73.39M |
|
$73.42M |
|
$288.23M |
|
$361.62M |
|
$-196.41M |
|
$-196.41M |
|
|
Shareholders Equity |
$-196.41M |
101.04M |
|
| Cash Flow Statement Financials | |
$2.72M |
|
$-0.02M |
|
$-0.09M |
|
$102.18M |
|
$106.20M |
|
$4.02M |
|
$2.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.02 |
|
-- |
|
-- |
|
-0.60 |
|
-0.37 |
|
90.80% |
|
-544.72% |
|
-544.72% |
|
-- |
|
-612.05% |
|
169.37% |
|
$2.70M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.08 |
|
18.63 |
|
4.83 |
|
8.54% |
|
8.54% |
|
-10.15% |
|
13.63% |
|
$-1.94 |
|
$0.03 |
|
$0.03 |
|